Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112723
Status:
TERMINATED
Last Update Posted:
2016-08-08
First Post:
2005-06-02
Brief Title:
Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Lymphocyte Depletion Hodgkin Lymphoma |
| Adult Lymphocyte Predominant Hodgkin Lymphoma |
| Adult Mixed Cellularity Hodgkin Lymphoma |
| Adult Nodular Sclerosis Hodgkin Lymphoma |
| Anaplastic Large Cell Lymphoma |
| Angioimmunoblastic T-cell Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult Diffuse Mixed Cell Lymphoma |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Adult Grade III Lymphomatoid Granulomatosis |
| Recurrent Adult Hodgkin Lymphoma |
| Recurrent Adult T-cell LeukemiaLymphoma |
| Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Grade 3 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Mycosis FungoidesSezary Syndrome |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Multiple Myeloma |
| Splenic Marginal Zone Lymphoma |
| Stage I Multiple Myeloma |
| Stage II Multiple Myeloma |
| Stage III Multiple Myeloma |
| Waldenström Macroglobulinemia |
Keywords: